Cargando…
THU494 VHL Protein Deficiency Alters The Immune Microenvironment Of Pancreatic Neuroendocrine Neoplasms
Disclosure: A. Chmelnik: None. A. Telerman: None. A. Tirosh: None. Introduction - Pancreatic neuroendocrine tumors (PanNENs) may develop sporadically or as part of an inherited disease, such as von Hippel-Lindau (VHL). VHL disease is caused by a germline pathogenic variant in the VHL gene encoding V...
Autores principales: | Chmelnik, Adiel, Telerman, Alona, Tirosh, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553718/ http://dx.doi.org/10.1210/jendso/bvad114.2122 |
Ejemplares similares
-
THU487 Xenograft of VHL-deficient Pancreatic Neuroendocrine Neoplasm Cells - A Novel Low-grade PNEN In Vivo Model
por: Telerman, Alona, et al.
Publicado: (2023) -
THU508 Does Mid-treatment Response To 177Lu-DOTATATE Predict Treatment Outcome In Patients With Neuroendocrine Neoplasms?
por: Halperin, Reut, et al.
Publicado: (2023) -
THU541 Impact Of Gender On Treatment Decisions And Outcome In Patients With Neuroendocrine Neoplasms
por: Beck, Julia, et al.
Publicado: (2023) -
THU521 A Case Of Multifocal Pancreatic Neuroendocrine Tumor With Multiple Twists
por: Syeda, Asma, et al.
Publicado: (2023) -
THU511 Somatostatin Analogs Or Active Surveillance In Sporadic And MEN1 Associated Non-functioning Pancreatic Neuroendocrine Tumors
por: Raia, Salvatore, et al.
Publicado: (2023)